Suppr超能文献

辐射与抗坏血酸联合作用下人类细胞基因组的不稳定

Destabilization of human cell genome under the combined effect of radiation and ascorbic acid.

作者信息

Domina E A, Pylypchuk O P, Mikhailenko V M

机构信息

R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine, Kyiv 03022, Ukraine.

出版信息

Exp Oncol. 2014 Dec;36(4):236-40.

Abstract

UNLABELLED

The aim of this study was to investigate peculiarities of ascorbic acid effect on radiation-induced chromosomal aberrations frequency and range in the cultured peripheral blood lymphocytes (PBL) of healthy donors and cancer patients depending on doses of radiation and drug, as well as cells radiosensitivity (in vitro).

METHODS

Test system of human PBL, metaphase analysis of chromosomal aberrations. Cells were cultivated according to the standard procedures with some modifications. PBL culture was exposed to x-ray radiation in G0- and G2-phases of cell cycle. Immediately after the irradiation the culture was treated with ascorbic acid in concentrations of 20.0-80.0 µg/ml of blood.

RESULTS

Cell culture irradiation in low dose (0.3 Gy) and treatment with ascorbic acid in therapeutic concentration (20.0 μg/ml of blood) resulted in radioprotective effect, decreasing overall chromosome aberrations frequency as opposed to radiation effects. It has been established that post-irradiation effect of ascorbic acid upon the PBL culture in concentrations of 40.0 and 80.0 μg/ml, which exceeding therapeutic concentration value 2 and 4 times correspondingly, increased overall chromosome aberrations frequency 1.4 times compared with irradiation effect in a low dose (0.3 Gy). This bears evidence of ascorbic acid co-mutagenic activity in the range of concentrations exceeding therapeutic values. The peak of mitotic activity inhibition was observed at 2.0 Gy irradiation dose. Addition ascorbic acid in therapeutic concentration increased radiation effect this number ≈ 2 times (exceeding even intact control value). Compared with G0-phase, co-mutagenic effect of ascorbic acid in G2-phase appears earlier, starting with dose of 1.0 Gy. In the blood lymphocytes of cancer patients, the level of genetic damage was increased 1.7 times after combined treatment with low dose irradiation and ascorbic acid in comparison with irradiation alone which suggest the co-mutagenic instead of radioprotective effect of ascorbic acid.

CONCLUSIONS

Genome destabilization enhancement of irradiated in vitro human somatic cells under ascorbic acid effect is due to its co-mutagenic properties. The formation of co-mutagenic effects of ascorbic acid depend on its concentration, irradiation dose and the efficiency of repair processes. Co-mutagenes may pose high carcinogenic hazard at low (above background) radiation levels.

摘要

未标记

本研究的目的是根据辐射剂量和药物剂量以及细胞放射敏感性(体外),研究抗坏血酸对健康供体和癌症患者培养的外周血淋巴细胞(PBL)中辐射诱导的染色体畸变频率和范围的影响特点。

方法

人PBL测试系统,染色体畸变的中期分析。细胞培养按照标准程序并做了一些修改。PBL培养物在细胞周期的G0期和G2期接受X射线辐射。照射后立即用浓度为20.0 - 80.0μg/ml血液的抗坏血酸处理培养物。

结果

低剂量(0.3Gy)照射细胞培养物并用治疗浓度(20.0μg/ml血液)的抗坏血酸处理产生了辐射防护作用,与辐射效应相反,降低了总体染色体畸变频率。已经确定,浓度为40.0和80.0μg/ml的抗坏血酸在照射后对PBL培养物的作用,分别超过治疗浓度值2倍和4倍,与低剂量(0.3Gy)照射效应相比,总体染色体畸变频率增加了1.4倍。这证明了抗坏血酸在超过治疗值的浓度范围内具有共诱变活性。在2.0Gy照射剂量下观察到有丝分裂活性抑制的峰值。添加治疗浓度的抗坏血酸使辐射效应增加了约2倍(甚至超过完整对照值)。与G0期相比,抗坏血酸在G2期的共诱变效应出现得更早,从1.0Gy剂量开始。在癌症患者的血液淋巴细胞中,与单独照射相比,低剂量照射和抗坏血酸联合治疗后遗传损伤水平增加了1.7倍,这表明抗坏血酸具有共诱变而非辐射防护作用。

结论

抗坏血酸作用下体外照射的人体体细胞基因组不稳定增强是由于其共诱变特性。抗坏血酸共诱变效应的形成取决于其浓度、照射剂量和修复过程的效率。共诱变剂在低(高于背景)辐射水平下可能构成高致癌风险。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验